Clinical Trial Update: PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PEP-CMV in recurrent medulloblastoma and malignant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma
• Medulloblastoma

Drugs mentioned

• PEP-CMV

Snippet

Sponsor: Daniel Landi | Conditions: Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood | Phase 1 | Status: ACTIVE_NOT_RECRUITING